• Home
  • COVID-19
    • Infection Control Program
    • Environment Control Program
  • About Us
    • Leadership
      • Board of Directors
      • Consultants
      • Our Team
    • Partners
  • Product
    • Infectious Diseases – dxn1
      • Rapid Infection Detection (RID)
      • dxn1 BactFast
      • dxn1 FungiFast
      • dxn1 Virfast
    • Predictive – GSeek
      • GSeek Exome
      • GSeek Breast
      • GSeek ColoRectal
      • GSeek Newborn Screening
      • GSeek Carrier Screening
    • Personalized Medicine – GSeek
      • GSeek Tumor Hotspots
    • Fertility – GScan
      • Non-Invasive GScan (NIPT)
  • Services
    • Clinical Diagnosis
    • Research
  • Technology
    • NGS
    • Genetic Consultation
    • Case Studies
      • Local
      • International
      • Archives
  • FAQs
  • Testimonials
  • Contact Us

Credence Genomics Credence Genomics

Credence Genomics

  • Home
  • COVID-19
    • Infection Control Program
    • Environment Control Program
  • About Us
    • Leadership
      • Board of Directors
      • Consultants
      • Our Team
    • Partners
  • Product
    • Infectious Diseases – dxn1
      • Rapid Infection Detection (RID)
      • dxn1 BactFast
      • dxn1 FungiFast
      • dxn1 Virfast
    • Predictive – GSeek
      • GSeek Exome
      • GSeek Breast
      • GSeek ColoRectal
      • GSeek Newborn Screening
      • GSeek Carrier Screening
    • Personalized Medicine – GSeek
      • GSeek Tumor Hotspots
    • Fertility – GScan
      • Non-Invasive GScan (NIPT)
  • Services
    • Clinical Diagnosis
    • Research
  • Technology
    • NGS
    • Genetic Consultation
    • Case Studies
      • Local
      • International
      • Archives
  • FAQs
  • Testimonials
  • Contact Us

Introducing GSeek Colorectal

GSeek Breast and GSeek Colorectal are the two gene panels designed for predisposition screening. Credence Comprehensive Breast Cancer Panel (GSeek Breast) enables simultaneous testing of the commonest breast cancer predisposition genes including the most famous markers BRCA1 and BRCA2. Credence Comprehensive Colorectal Panel (GSeek ColoRectal) sequences 17 genes, for testing of the commonest colorectal cancer predisposition.

How does genetic predisposition testing help?

Genetic predispositions or genetic susceptibility increases the likelihood in a person of developing a genetically inherited disease, depending on his or her genetic makeup.  These genetic changes contribute to the development of a disease but do not directly cause it. Genetic predisposition testing therefore helps in evaluating a person’s risk for developing a genetic based disease or for passing a genetic disease on to their offspring. This knowledge may guide the decisions an individual and his or her doctor make about your health care, including possible treatment options, additional testing and screening or family planning. Using this genetic information, the doctors can work with their patients proactively to help them make choices that may lead to healthier lives.

Once detected, the information generated by the test can help the individuals and their families take preventive measures to lead a healthier, symptom free long life.

101738585

GSeek ColoRectal Screening Panel

GSeek ColoRectal Screening Panel simultaneously screens 17 genes that are responsible for inherited predisposition to ColoRectal Cancer.  The genes covered in the panel include;

APC, ATM, AXIN2, BMPR1A, CDH1, CHEK2, EPCAM, MLH1, MSH2, MSH6, MUTYH, PMS2, PTEN, SMAD4, STK11, TP53 and XRCC2.

Key points

  • Test whether you are genetically predisposed towards colorectal cancer
  • Credence testing panel covers 17 different genes responsible for colorectal cancer
  • Comprehensive testing with 99.7% accuracy
  • Best possible action plans if predisposed towards colorectal cancer
  • Benefit from early diagnosis, reduced medical costs and peace of mind

Did you know?

Some carry a life-time fear of acquiring major genetic conditions like cancer or heart conditions from the very moment a first degree relative is identified with similar diseases.

GSeek Breast

GSeek Newborn

Get in touch

12-3/2 Sunethra Devi Road,
Kohuwala, Sri Lanka.

Phone: 011 2890687 / 011 2818370
Hotline: +94 71 038 0011
Email: info@credencegenomics.com

Search...

Call me back

Please fill out this form if you would want us to call you back.

captcha

Latest News Feed

https://www.credencegenomics.com/news/apollo-india-launches-dna-based-diagnostics-with-sri-lankas-credence-genomics/

Apollo India launches DNA based diagnostics with Sri Lanka’s Credence Genomics

December 3, 2017

Chennai – The Apollo Hospitals Group, India’s largest integrated... Read More

https://www.credencegenomics.com/news/eye-live-interview-dr-vaz-santosh-gnanam-ceo-director-credence-genomics/

EYE LIVE INTERVIEW DR. VAZ SANTOSH GNANAM – CEO / DIRECTOR – CREDENCE GENOMICS

December 2, 2017

Eye Live morning TV show interviewing Dr. Vaz Santosh... Read More

https://www.credencegenomics.com/news/bmc-infectious-diseases-publishes-credence-rid-bactfast-fungifast/

BMC Infectious Diseases publishes Credence RID, Bactfast & Fungifast

December 2, 2017

Credence Genomics Ltd., Sri Lanka’s premier specialised DNA diagnostics... Read More

News Archive

© Credence Genomics 2022. BenWorldwide | Feedback

Thank you

Your inquiry has been received.

Close